[Home ] [Archive]    
:: Home :: About Journal :: Registration :: Article Submission :: Contact us :: Site Map ::
:: Volume 14, Issue 2 (March-2022 2022) ::
IJBC 2022, 14(2): 49-57 Back to browse issues page
CMV-colitis in a pediatric non-transplant ALL patient receiving chemotherapy; A case report
Bahram Darbandi, Parham Niyasti, Shohreh Maleknejad, Adel Baghersalimi, Houman Hashemian, Arezoo Karimzadeh *
Pediatric Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran
Abstract:   (210 Views)
Cytomegalovirus (CMV) is the leading cause of viral-associated congenital infections. Moreover, it can also be acquired. Between 50 to 80 percent of the world’s population is seropositive for CMV and most clinical disease occurs in individuals previously infected with CMV. Rarely, serious CMV infection has occurred in individuals with healthy immune system. In contrast to immunocompetent patients, higher morbidity and mortality of CMV end organ disease is considered in immunocompromised patients. According to available evidence, gastrointestinal (GI) disease has lower prevalence in case of CMV-induced organ involvement, especially in pediatric non-transplant acute leukemia. In this report, we present a 12-year-old girl, known case of acute lymphoblastic leukemia (ALL) receiving maintenance chemotherapy with manifestations of gastroenteritis and significant weight loss. Initial laboratory data, demonstrated mild pancytopenia especially lymphopenia and thrombocytopenia. After excluding more common etiologies, colonoscopy with multiple biopsies were taken which was indicative of CMV-colitis. Intravenous (IV) ganciclovir for 3 weeks and oral valganciclovir for about 9 months were initiated. Follow-up courses for CMV surveillance included blood qualitative CMV polymerase chain reaction (PCR) and colonoscopy with biopsy which were negative for CMV but tissue qualitative CMV PCR was positive for CMV in about 7 months after initiation of treatment. Oral treatment was decided to be continued. To sum up, plenty of guidelines have been developed in stem cell transplantation and human immunodeficiency virus (HIV) patients but non-transplant leukemic setting, is a neglected area in the field of CMV infection management.
Keywords: Acute Leukemia, Colitis, Cytomegalovirus
Full-Text [PDF 859 kb]   (112 Downloads)    
: case report | Subject: Pediatric Hematology & Oncology
Received: 2021/12/4 | Accepted: 2022/06/4 | Published: 2022/06/28
* Corresponding Author Address: Pediatric Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML     Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Darbandi B, Niyasti P, Maleknejad S, Baghersalimi A, Hashemian H, Karimzadeh A. CMV-colitis in a pediatric non-transplant ALL patient receiving chemotherapy; A case report. IJBC. 2022; 14 (2) :49-57
URL: http://ijbc.ir/article-1-1174-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 14, Issue 2 (March-2022 2022) Back to browse issues page
مجله ی خون و سرطان ایران Iranian Journal of Blood and Cancer
Persian site map - English site map - Created in 0.05 seconds with 30 queries by YEKTAWEB 4457